Sudden Cardiac Death in Dialysis: Do Current Guidelines for Implantable Cardioverter Defibrillator Therapy Apply to Patients with End-stage Kidney Disease?

Seminars in Dialysis

Volumn 25, Issue 3, 2012, Pages 272-276

  O'Shaughnessy, Michelle M ^a   Lappin, David W ^b,c   Reddan, Donal N ^b,c  

^a BEAUMONT HOSPITAL   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVERSION; CHRONIC KIDNEY FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; STANDARD; SUDDEN DEATH; SURVIVAL RATE; UNITED STATES;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; KIDNEY FAILURE, CHRONIC; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 84861226657     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2012.01067.x     Document Type: Article

References (41)

1. US Renal Data System: USRDS 2010 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
2. Rea TD, Pearce RM, Raghunathan TE, Lemaitre RN, Sotoodehnia N, Jouven X, Siscovick DS: Incidence of out-of-hospital cardiac arrest. Am J Cardiol 93:1455-1460, 2004
3. Parfrey P, Foley S: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10:1606-1615, 1999
4. US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
5. Shamseddin M, Parfrey P: Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol 7:145-154, 2011
6. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS: Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21:2071-2078, 2000
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877-883, 2002
8. Bardy GH, Lee KL, Mark DB, Poole EJ, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH: Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 352:225-237, 2005
9. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA, III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, American College of Cardiology/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons: ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. J Am Coll Cardiol 51:2085-2105, 2008
10. Reddan DN: Therapy for cardiovascular disease in patients with chronic kidney disease: appropriate caution or the absence of data. Am Heart J 144:206-207, 2002
11. Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E: Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 80:572-586, 2011
12. Herzog CA, Strief JW, Collins AJ, Gilbertson DT: Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention? Nephrol Dial Transplant 23:2629-2633, 2008
13. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabrò R: Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 41:1438-1444, 2003
14. Zannad F, Kessler M, Lehert P, Grunfeld JP, Thuilliez C, Leizorovicz A, Lechat P: Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies. Kidney Int 70:1318-1324, 2006
15. Takahashi A, Takase H, Toriyama T, Sugiura T, Kurita Y, Ueda R, Dohi Y: Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis: A randomized study. Nephrol Dial Transplant 21:2507-2512, 2006
16. Wanner C, Krane V, Marz W, Olschewski M, Mann JFE, Ruf G, Ritz E, the German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238-248, 2005
17. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R, SHARP Investigators: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377:2181-2192, 2011
18. Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP: Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int 79:218-227, 2011
19. Foley RN, Gilbertson DT, Murray T, Collins AJ: Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis. N Engl J Med 365:1099-1107, 2011
20. Pun PH, Lehrich RW, Smith SR, Middleton JP: Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2:491-500, 2007
21. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 45(Suppl. 3):S1-S154, 2005
22. Lehrich RW, Pun PH, Tanenbaum ND, Smith SR, Middleton JP: Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic. J Am Soc Nephrol 18:312-320, 2007
23. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT: Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68:818-825, 2005
24. Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA: Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol 19:1275-1280, 2008
25. Hreybe H, Ezzeddine R, Bedi M, Barrington W, Bazaz R, Ganz LI, Jain S, Ngwu O, London B, Saba S: Renal insufficiency predicts the time to first appropriate defibrillator shock. Am Heart J 151:852-856, 2006
26. Cuculich PS, Sanchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD: Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 30:207-213, 2007
27. Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C, Quadrini M, Hsu J, Fan J, Choi P, Kadish A, Goldberger J, Passman R: Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter defibrillator recipients. Heart Rhythm 3:1196-1201, 2006
28. Hreybe H, Razak E, Saba S: Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 30:1091-1095, 2007
29. Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH: Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 17:940-943, 2006
30. Sakhuja R, Keebler M, Lai TS, McLaughlin Gavin C, Thakur R, Bhatt DL: Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 103:735-741, 2009
31. Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Goldberger J, Passman R: Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 49:656-663, 2007
32. Teruya TH, Abou-Zamzam Jr AM, Limm W, Wong L, Wong L: Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers. Ann Vasc Surg 17:526-529, 2003
33. Asif A, Carrillo R, Garisto JD, Lopera G, Ladino M, Barakat U, Eld N, Salman L: Epicardial rhythm devices for dialysis patients: minimizing the risk of infection and preserving central veins. Semin Dial advance online publication, 27 August 2010
34. Asif A, Salman L, Lopera G, Carrillo R: The dilemma of transvenous cardiac rhythm devices in hemodialysis patients: time to consider the epicardial approach? Kidney Int 79:1267-1269, 2011
35. Wase A, Basit A, Nazir R, Jamal A, Shah S, Khan T, Mohiuddin I, White C, Saklayen M, McCullough PA: Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 11:199-204, 2004
36. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M: The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113:1424-1433, 2006
37. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G: Characteristics of sudden death in hemodialysis patients. Kidney Int 69:2268-2273, 2006
38. Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey PS: The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 65:212-214, 1993
39. Marcassi AP, Yasbek DC, Pestana JO, Fachini FC, De Lira Filho EB, Cassiolato JL, Canziani ME: Ventricular arrhythmia in incident kidney transplant recipients: prevalence and associated factors. Transpl Int 24:67-72, 2011
40. de Bie MK, Lekkerkerker JC, van Dam B, Gaasbeek A, van Buren M, Putter H, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW: Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study. Curr Med Res Opin 24:2151-2157, 2008
41. Sanders GD, Hlatky MA, Owens DK: Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 353:1471-1480, 2005